First Time Loading...

Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016

Watchlist Manager
Shanghai MicroPort Endovascular MedTech Group Co Ltd Logo
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Watchlist
Price: 121.5 CNY 0.92% Market Closed
Updated: May 16, 2024
Section:
 

Relative Value

The Relative Value of one Shanghai MicroPort Endovascular MedTech Group Co Ltd stock under the Base Case scenario is 163.53 CNY. Compared to the current market price of 121.5 CNY, Shanghai MicroPort Endovascular MedTech Group Co Ltd is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
163.53 CNY
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

11.9
P/S
P/S
Price to Sales
11.9
vs History
96
vs Industry
18
Median 3Y
15
Median 5Y
22.8
Industry
2.4
Forward
9.6
More Details
27.1
P/E
P/E
Price to Earnings
27.1
vs History
96
vs Industry
31
Median 3Y
37
Median 5Y
49.4
Industry
23.9
Forward
22.6
More Details
23
P/OCF
P/OCF
Price to OCF
23
vs History
96
vs Industry
28
Median 3Y
39.9
Median 5Y
50.9
Industry
15.6
More Details
32.7
P/FCFE
P/FCFE
Price to FCFE
32.7
vs History
91
vs Industry
24
Median 3Y
73.8
Median 5Y
83.8
Industry
22.5
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
96
vs Industry
36
Median 3Y
7.8
Median 5Y
9
Industry
2.3
More Details
9.4
EV/S
EV/S
Enterprise Value to Sales
9.4
vs History
96
vs Industry
23
Median 3Y
13.9
Median 5Y
21.1
Industry
2.5
Forward
7.6
More Details
12.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.4
vs History
96
vs Industry
32
Median 3Y
18.6
Median 5Y
27
Industry
5.3
More Details
19
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19
vs History
96
vs Industry
32
Median 3Y
31.2
Median 5Y
42.1
Industry
12.9
Forward
15.8
More Details
19
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19
vs History
96
vs Industry
38
Median 3Y
31.2
Median 5Y
42.1
Industry
17.8
Forward
17.1
More Details
18.2
EV/OCF
EV/OCF
Enterprise Value to OCF
18.2
vs History
96
vs Industry
38
Median 3Y
36.4
Median 5Y
46.9
Industry
15.4
More Details
25.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.8
vs History
91
vs Industry
30
Median 3Y
69.1
Median 5Y
77.3
Industry
19.6
More Details
9.1
EV/IC
EV/IC
Enterprise Value to IC
9.1
vs History
96
vs Industry
17
Median 3Y
14.9
Median 5Y
28.6
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai MicroPort Endovascular MedTech Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
15B CNY 11.9 27.1 19 19
CH
Alcon AG
SIX:ALC
40B CHF 4.7 45.6 20.1 40.8
JP
Hoya Corp
TSE:7741
6.8T JPY 9 40.5 24.7 30.5
DK
Coloplast A/S
CSE:COLO B
189.2B DKK 7.5 38.8 25.5 29.7
US
Align Technology Inc
NASDAQ:ALGN
21.1B USD 5.4 45.6 25 30.4
US
Cooper Companies Inc
NYSE:COO
19.5B USD 5.3 66.9 24.2 41.2
KR
HLB Inc
KOSDAQ:028300
12.4T KRW 286.4 -65 -105.8 -97.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
58.8B CNY 14.4 33.9 29.9 29.9
UK
ConvaTec Group PLC
LSE:CTEC
5.1B GBP 3 53.1 46.9 51
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -61.8 11.7 26.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD 4 12 10 11.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.